French decree confirms separate payment for ICDs and vascular implants:
This article was originally published in Clinica
Executive Summary
The French health ministry has published a decree confirming that implantable defibrillators and vascular implants are to be paid for separately from the standard stay group (GHS) tariffs. This is the French equivalent of the diagnosis-related group scheme of charging for hospital treatment. The decree, dated July 29, was published in the Journal officiel on September 2 and contains a list of the codes that specify the precise implants covered by the ruling.
You may also be interested in...
Keep Makena Under Accelerated Approval Pending More Studies, AMAG Tells US FDA
AMAG outlines plans for retrospective real-world evidence studies, and possibly a new placebo-controlled trial with a primary endpoint of preterm birth <32 weeks, in a filing opposing the Center for Drug Evaluation and Research’s proposal to withdraw the drug.
World-First Nod For Yuhan's Lung Cancer Drug, In Korea
The leading Korean pharma firm’s oral, third-generation EGFR-TKI is approved in the country, providing a new option for patients with advanced NSCLC and increasing hopes for global approvals given an ongoing global Phase III combination trial led by partner J&J.
DePuy Synthes Gains US FDA Clearance For Velys Robot For Total Knee Surgery
DePuy Synthes expects its Velys robotic-assisted system to be cost-effective, easy-to-use and to be well-suited for use in ambulatory surgery centers.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: